The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berguer, P. M.
Right arrow Articles by Goldbaum, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berguer, P. M.
Right arrow Articles by Goldbaum, F. A.
The Journal of Immunology, 2006, 176: 2366-2372.
Copyright © 2006 by The American Association of Immunologists

A Polymeric Bacterial Protein Activates Dendritic Cells via TLR41

Paula M. Berguer*, Juliana Mundiñano{dagger}, Isabel Piazzon2,{dagger} and Fernando A. Goldbaum2,3,*

* Fundación Instituto Leloir, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina; and {dagger} ILEX-Consejo Nacional de Investigaciones Científicas y Técnicas, División Medicina Experimental, Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, Buenos Aires, Argentina

The enzyme lumazine synthase from Brucella spp. (BLS) is a highly immunogenic protein that folds as a stable dimer of pentamers. It is possible to insert foreign peptides and proteins at the 10 N terminus of BLS without disrupting its general folding, and these chimeras are very efficient to elicit systemic and oral immunity without adjuvants. In this study, we show that BLS stimulates bone marrow dendritic cells from mice in vitro to up-regulate the levels of costimulatory molecules (CD40, CD80, and CD86) and major histocompatibility class II Ag. Furthermore, the mRNA levels of several chemokines are increased, and proinflammatory cytokine secretion is induced upon exposure to BLS. In vivo, BLS increases the number of dendritic cells and their expression of CD62L in the draining lymph node. All of the observed effects are dependent on TLR4, and clearly independent of LPS contamination. The described characteristics of BLS make this protein an excellent candidate for vaccine development.




This article has been cited by other articles:


Home page
J. Immunol.Home page
G. C. Macedo, D. M. Magnani, N. B. Carvalho, O. Bruna-Romero, R. T. Gazzinelli, and S. C. Oliveira
Central Role of MyD88-Dependent Dendritic Cell Maturation and Proinflammatory Cytokine Production to Control Brucella abortus Infection
J. Immunol., January 15, 2008; 180(2): 1080 - 1087.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
V. Zylberman, S. Klinke, I. Haase, A. Bacher, M. Fischer, and F. A. Goldbaum
Evolution of vitamin b2 biosynthesis: 6,7-dimethyl-8-ribityllumazine synthases of Brucella.
J. Bacteriol., September 1, 2006; 188(17): 6135 - 6142.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.